First pass effect in posterior circulation occlusions: Analysis from the CICAT registry.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 12 3 2022
medline: 1 2 2023
entrez: 11 3 2022
Statut: ppublish

Résumé

The first pass effect (FPE) is an independent predictor of functional independence in patients with large vessel occlusion in anterior circulation ischemic strokes. However, whether it predicts outcome in posterior circulation large vessel occlusion (PC-LVO) is uncertain. We aimed to study the frequency, characteristics, and predictors of FPE and its association with clinical outcomes in PC-LVO. We performed an analysis from the prospective CICAT Registry. All patients with PC-LVO who underwent endovascular therapy between January 2016 and January 2020 were included. A centrally assessed clinical follow-up was performed at 3 months by blinded investigators. FPE was defined as the achievement of modified Thrombolysis In Cerebral Infarction 3 in a single pass of the endovascular thrombectomy device, and multi-pass effect (MPE) if it was achieved in more than one pass. A multivariable analysis was performed to identify whether FPE is an independent predictor of functional independence defined as a modified Rankin Score of 0-2. We analyzed data from 265 patients in who FPE was achieved in 105 (39.6%). Patients with FPE were more likely to achieve functional independence compared to the non-FPE group (52.4% vs 25.1%, FPE is an independent predictor of functional independence in PC-LVO and was associated with a significantly better outcome than MPE.

Sections du résumé

BACKGROUND
The first pass effect (FPE) is an independent predictor of functional independence in patients with large vessel occlusion in anterior circulation ischemic strokes. However, whether it predicts outcome in posterior circulation large vessel occlusion (PC-LVO) is uncertain. We aimed to study the frequency, characteristics, and predictors of FPE and its association with clinical outcomes in PC-LVO.
METHOD
We performed an analysis from the prospective CICAT Registry. All patients with PC-LVO who underwent endovascular therapy between January 2016 and January 2020 were included. A centrally assessed clinical follow-up was performed at 3 months by blinded investigators. FPE was defined as the achievement of modified Thrombolysis In Cerebral Infarction 3 in a single pass of the endovascular thrombectomy device, and multi-pass effect (MPE) if it was achieved in more than one pass. A multivariable analysis was performed to identify whether FPE is an independent predictor of functional independence defined as a modified Rankin Score of 0-2.
RESULTS
We analyzed data from 265 patients in who FPE was achieved in 105 (39.6%). Patients with FPE were more likely to achieve functional independence compared to the non-FPE group (52.4% vs 25.1%,
CONCLUSIONS
FPE is an independent predictor of functional independence in PC-LVO and was associated with a significantly better outcome than MPE.

Identifiants

pubmed: 35272563
doi: 10.1177/17474930221089772
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-228

Auteurs

Mikel Terceño (M)

Stroke Unit, Department of Neurology, Girona Biomedical Research Institute (IDIBGI), Doctor Josep Trueta Hospital, Girona, Spain.
Interventional Neuroradiology Unit, Department of Neurosciences, Germans Trias i Pujol Hospital, Badalona, Spain.

Yolanda Silva (Y)

Stroke Unit, Department of Neurology, Girona Biomedical Research Institute (IDIBGI), Doctor Josep Trueta Hospital, Girona, Spain.

Saima Bashir (S)

Stroke Unit, Department of Neurology, Girona Biomedical Research Institute (IDIBGI), Doctor Josep Trueta Hospital, Girona, Spain.

Ángel Chamorro (Á)

Stroke Unit, Department of Neurology, Clinic Hospital, Barcelona, Spain.

Natalia Pérez de la Ossa (N)

Stroke Unit, Department of Neurosciences, Germans Trias i Pujol Hospital, Badalona, Spain.
Stroke Program/Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain.

María Hernandez-Pérez (M)

Stroke Unit, Department of Neurosciences, Germans Trias i Pujol Hospital, Badalona, Spain.

Carlos Castaño (C)

Interventional Neuroradiology Unit, Department of Neurosciences, Germans Trias i Pujol Hospital, Badalona, Spain.

Pol Camps-Renom (P)

Stroke Unit, Department of Neurology, Santa Creu i Sant Pau Hospital, Barcelona, Spain.

Denisse Wenger (D)

Stroke Unit, Department of Neurosciences, Germans Trias i Pujol Hospital, Badalona, Spain.

Pere Cardona (P)

Stroke Unit, Department of Neurology, Bellvitge Hospital, Barcelona, Spain.

Carlos Molina (C)

Stroke Unit, Department of Neurology, Vall d'Hebron Hospital, Barcelona, Spain.

Ana Rodríguez-Campello (A)

Stroke Unit, Department of Neurology, Mar Hospital, Barcelona, Spain.

David Cánovas (D)

Stroke Unit, Department of Neurology, Parc Taulí Hospital, Sabadell, Spain.

Francisco Purroy (F)

Stroke Unit, Department of Neurology, Arnau de Vilanova Hospital, IRBLleida, University of Lleida, Lleida, Spain.

Mercè Salvat-Plana (M)

Catalan Stroke Programme, Catalan Public Health Department, Barcelona, Spain.

Joaquín Serena (J)

Stroke Unit, Department of Neurology, Girona Biomedical Research Institute (IDIBGI), Doctor Josep Trueta Hospital, Girona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH